Recent advances in human stem cell-based modeling of Tuberous Sclerosis Complex

Area of Science:

• Neuroscience
• Genetics
• Stem Cell Biology

Background:

• Tuberous Sclerosis Complex (TSC) is an autosomal dominant disorder impacting brain development, causing epilepsy, intellectual disability, and tumors.
• Traditional animal models struggle to fully replicate human TSC pathology.
• Human induced pluripotent stem cells (hiPSCs) provide a promising avenue for disease modeling.

Purpose of the Study:

• To review the utility of hiPSCs for modeling Tuberous Sclerosis Complex.
• To explore the application of gene-editing technologies like CRISPR/Cas9 in TSC research.
• To discuss the potential and limitations of hiPSC-based TSC models.

Main Methods:

• Derivation of hiPSCs from TSC patients.
• Utilizing CRISPR/Cas9 for gene editing to create isogenic controls.
• Differentiation of hiPSCs into relevant cell types for modeling.
• Application of 2D and 3D cell culture techniques.

Main Results:

• hiPSCs preserve patient-specific genetic backgrounds for accurate modeling.
• Gene editing allows for the generation of precise isogenic controls.
• hiPSC-derived models demonstrate capacity for studying TSC pathogenesis.
• Variability in iPSC models and reported findings requires careful consideration.

Conclusions:

• hiPSC technology, combined with gene editing, offers a robust platform for Tuberous Sclerosis Complex research.
• These models facilitate the study of TSC in patient-specific contexts and various cellular systems.
• Further research is needed to address model variability and standardize findings.